HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.

Abstract
Childhood cerebral form of X-linked adrenoleukodystrophy (X-ALD) is a rapidly progressive demyelinating condition affecting the cerebral white matter, which rapidly leads to total disability and death. The only known curative treatment for this condition is allogeneic hematopoietic stem cell transplantation (HSCT). Procedure-related toxicity is assumed to be the cause of death of patients with X-ALD. Three cases of ALD successfully transplanted with the use of non-myeloablative fludarabine based conditioning are described. Patients showed smooth peri-bone marrow transplantation course with fast and stable engraftment. In the 3- to 5 yr follow-up period, patients showed no deterioration in their clinical and neurological condition. Levels of very long chain fatty acids were very variable and had a tendency to decrease in at least one of the three patients. In another patient, an improvement of magnetic resonance imaging changes was found. Non-myeloablative HSCT should be considered as an early treatment for X-ALD.
AuthorsIgor B Resnick, Ali Abdul Hai, Michael Y Shapira, Menachem Bitan, Eli Hershkovitz, Arie Schwartz, Miriam Ben-Harush, Reuven Or, Shimon Slavin, Joseph Kapelushnik
JournalClinical transplantation (Clin Transplant) Vol. 19 Issue 6 Pg. 840-7 (Dec 2005) ISSN: 0902-0063 [Print] Denmark
PMID16313334 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Myeloablative Agonists
  • Vidarabine
  • Busulfan
  • fludarabine
Topics
  • Adrenoleukodystrophy (surgery)
  • Busulfan (administration & dosage, therapeutic use)
  • Child
  • Drug Therapy, Combination
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Myeloablative Agonists (administration & dosage, therapeutic use)
  • Transplantation Conditioning (methods)
  • Vidarabine (administration & dosage, analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: